Aster DM Healthcare Investor Presentation - November 2025
Aster DM Healthcare releases investor presentation highlighting the merger with Quality Care, creating a leading hospital chain with 10,360+ beds. Q2 FY26 revenue at ₹1,197 Cr and EBITDA at ₹263 Cr.
The merger is a significant strategic move that will substantially increase the company's scale and market presence.
The announcement focuses on a merger expected to create a leading hospital chain and highlights positive financial performance.
* Aster DM Healthcare Limited has released an investor presentation as of September 30, 2025. * The presentation highlights the merger of Aster DM and Blackstone-backed Quality Care, creating one of the top 3 hospital chains in India with 10,360+ beds. * The merged entity will be named Aster DM Quality Care Limited. * Aster acquired a 5.0% stake in QCIL from Blackstone and TPG in consideration of primary share issuance by Aster for 3.6% stake, followed by a merger of QCIL into Aster. * The transaction values Aster at 36.6x FY24 Adj. Post INDAS EV/ EBITDA. * Inter-se shareholding between Aster DM and Quality Care shareholders would be 57.3% and 42.7% respectively. * Dr. Azad Moopen will continue as the Executive Chairman; Mr. Varun Khanna (Group MD, QCIL) and Mr. Sunil Kumar (CFO, Aster) will be promoted to MD & Group CEO and Group CFO, respectively. * The merged entity has a combined revenue of ₹8,105 crore (₹81.05 billion) and Operating EBITDA of ₹1,661 crore (₹16.61 billion). * The implementation of the scheme is expected to be completed by Q1 FY27, subject to necessary approvals. * The company's Q2 FY26 revenue from operations was ₹1,197 crore (₹11.97 billion), and Operating EBITDA was ₹263 crore (₹2.63 billion). * Normalised PAT for FY25 stood at ₹357 crore (₹3.57 billion). * The company projects a total addition of 4,345+ beds, funded through internal accruals/cash in hand, bringing the total bed capacity to 14,715+ beds.
What to do with a filing like this
Aster DM Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aster DM Healthcare Limited. Read the original for the full detail.